MA29406B1 - Vaccin toxoide alpha de c. perfringens - Google Patents
Vaccin toxoide alpha de c. perfringensInfo
- Publication number
- MA29406B1 MA29406B1 MA30321A MA30321A MA29406B1 MA 29406 B1 MA29406 B1 MA 29406B1 MA 30321 A MA30321 A MA 30321A MA 30321 A MA30321 A MA 30321A MA 29406 B1 MA29406 B1 MA 29406B1
- Authority
- MA
- Morocco
- Prior art keywords
- perfringens
- vaccines
- alpha
- toxoid vaccine
- alpha toxoid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/08—Clostridium, e.g. Clostridium tetani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0258—Escherichia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Dermatology (AREA)
- Gastroenterology & Hepatology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Abstract
LA PRÉSENTE INVENTION A TRAIT À DES VACCINS COMPORTANT DES TOXOÏDES C.PERFRINGENS DE TYPE ALPHA, DES FRAGMENTS ANTIGÉNIQUES DE CELLES-CI, DES FRAGMENTS ANTIGÉNIQUES INACTIVÉS DE TOXINES C.PERFRINGENS DE TYPE ALPHA, OU TOUTE COMBINAISON DE CEUX-CI. LA PRÉSENTE INVENTION A ÉGALEMENT TRAIT À DES PROCÉDÉS D'UTILISATION DE CES VACCINS POUR LA PROTECTION D'ANIMAUX CONTRE DES MALADIES CLOSTRIDIALES. LA PRÉSENTE INVENTION A TRAIT EN OUTRE À DES PROCÉDÉS DE FABRICATION DE TELS VACCINS.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US67228905P | 2005-04-18 | 2005-04-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA29406B1 true MA29406B1 (fr) | 2008-04-01 |
Family
ID=36820082
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA30321A MA29406B1 (fr) | 2005-04-18 | 2007-10-26 | Vaccin toxoide alpha de c. perfringens |
Country Status (25)
Country | Link |
---|---|
US (2) | US8980283B2 (fr) |
EP (1) | EP1874344B1 (fr) |
JP (2) | JP5243951B2 (fr) |
KR (1) | KR20080005277A (fr) |
CN (1) | CN101198352B (fr) |
AR (1) | AR054251A1 (fr) |
AU (1) | AU2006236365B2 (fr) |
BR (1) | BRPI0610843B1 (fr) |
CA (1) | CA2606180C (fr) |
CR (1) | CR9443A (fr) |
DK (1) | DK1874344T3 (fr) |
ES (1) | ES2583484T3 (fr) |
IL (1) | IL186701A0 (fr) |
MA (1) | MA29406B1 (fr) |
MX (1) | MX2007013053A (fr) |
MY (1) | MY149604A (fr) |
NZ (1) | NZ562637A (fr) |
PE (1) | PE20061398A1 (fr) |
RU (1) | RU2434638C2 (fr) |
SG (1) | SG186672A1 (fr) |
TN (1) | TNSN07387A1 (fr) |
TW (1) | TWI311057B (fr) |
UA (1) | UA98099C2 (fr) |
WO (1) | WO2006113772A1 (fr) |
ZA (1) | ZA200709516B (fr) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MY149604A (en) * | 2005-04-18 | 2013-09-13 | Schering Plough Ltd | C.perfringens alpha toxoid vaccine |
AU2007245198B2 (en) * | 2006-03-30 | 2010-08-12 | Zoetis Services Llc | Methods and compositions for vaccination of poultry |
MX2008013451A (es) * | 2006-04-17 | 2008-10-30 | Schering Plough Ltd | Organismos clostridium atenuados recombinantes y vacuna. |
AU2007313819A1 (en) * | 2006-10-27 | 2008-05-08 | Dow Agrosciences Llc | Poultry vaccine, for necrotic enteritis, comprising a mutated Clostridium perfringens alpha toxin antigen, and methods of producing the vaccine |
CA2669765A1 (fr) * | 2006-11-20 | 2008-05-29 | Intervet International B.V. | Utilisation d'une bacterie de clostridium perfringens type c pour la fabrication d'un vaccin |
CA2629790C (fr) * | 2007-04-12 | 2015-06-30 | Nutratech | Anticorps aviaires antimethanogenes permettant de diminuer la production de methane |
CA2685533C (fr) * | 2007-06-22 | 2019-07-02 | University Of Guelph | Vaccin contre <i>clostridium perfringens</i> |
US8956628B2 (en) * | 2007-12-13 | 2015-02-17 | Zoetis Products Llc | Bacteriophage preparations and method of use thereof |
US8293101B2 (en) | 2009-03-13 | 2012-10-23 | Terrasep, Llc | Methods and apparatus for centrifugal liquid chromatography |
WO2011103465A2 (fr) * | 2010-02-20 | 2011-08-25 | Alexey Gennadievich Zdanovsky | Compositions antigéniques comprenant la neurotoxine botulique et procédés associés |
WO2011151941A1 (fr) * | 2010-06-04 | 2011-12-08 | 国立大学法人東京大学 | Composition présentant une activité d'induction de la prolifération ou de l'accumulation de cellule t régulatrice |
CN102008720B (zh) * | 2010-07-20 | 2015-02-25 | 东北农业大学 | 抗魏氏梭菌病转基因植物疫苗及其制作方法 |
WO2013091895A1 (fr) * | 2011-12-23 | 2013-06-27 | Merz Pharma Gmbh & Co. Kgaa | Nouveau procédé pour la fabrication de protéines di-chaînes pour utilisation dans les êtres humains |
CN102657683B (zh) * | 2012-06-02 | 2014-05-07 | 哈尔滨工业大学 | 一种免疫类毒素的制备方法 |
CN102698259B (zh) * | 2012-06-12 | 2017-02-08 | 北京中海生物科技有限公司 | 一种鸡坏死性肠炎(a型)灭活疫苗制备方法 |
CN102688484B (zh) * | 2012-06-13 | 2016-03-30 | 北京中海生物科技有限公司 | 一种鸡坏死性肠炎(c型)灭活疫苗的生产方法 |
EP2911688B1 (fr) | 2012-10-26 | 2019-10-16 | Intervet International B.V. | Vaccins de protection croisée contre la salmonelle |
CN103463632B (zh) * | 2013-09-05 | 2016-01-06 | 山东农业大学 | 牛羊肠毒血症的d型产气荚膜梭菌类毒素疫苗的制备方法 |
FR3012964A1 (fr) * | 2013-11-12 | 2015-05-15 | Seppic Sa | Vaccins adjuves pour vaccination aviaire in ovo |
CN103861094A (zh) * | 2014-03-27 | 2014-06-18 | 山东农业大学 | 一种产气荚膜梭菌α毒素基因工程疫苗及其应用 |
CN104131022A (zh) * | 2014-08-01 | 2014-11-05 | 中国农业科学院兰州兽医研究所 | 产气荚膜梭菌α、β1、β2、ε毒素共表达载体及其构建方法和表达方法 |
CN104531731B (zh) * | 2014-12-15 | 2018-06-26 | 中国人民解放军军事医学科学院军事兽医研究所 | 产气荚膜梭菌α毒素人源化单链抗体7D |
CN104531730B (zh) * | 2014-12-15 | 2018-07-17 | 中国人民解放军军事医学科学院军事兽医研究所 | 产气荚膜梭菌α毒素人源化单链抗体8B |
CN104531867B (zh) * | 2014-12-25 | 2017-03-29 | 湖北省农业科学院畜牧兽医研究所 | 产气荚膜梭菌肠毒素阳性菌双重荧光定量pcr快速检测试剂盒 |
EP3112474A1 (fr) * | 2015-06-29 | 2017-01-04 | Evonik Degussa GmbH | Procédé de détection d'entérite nécrotique aviaire |
EP3571288A4 (fr) | 2017-01-23 | 2020-12-02 | University of Florida Research Foundation, Incorporated | Induction d'immunité protectrice contre des antigènes |
WO2018159476A1 (fr) * | 2017-02-28 | 2018-09-07 | 一般財団法人阪大微生物病研究会 | Vaccin polyvalent |
WO2018218360A1 (fr) * | 2017-05-31 | 2018-12-06 | Her Majesty The Queen In Right Of Canada As Represented By The Minister Of Agriculture And Agri-Food | Vaccin contre l'entérite nécrotique chez la volaille |
WO2018224595A1 (fr) * | 2017-06-09 | 2018-12-13 | Hipra Scientific, S.L.U. | Vaccin comprenant des anatoxines de clostridium |
EP3661547A4 (fr) * | 2017-08-04 | 2021-06-09 | University of Florida Research Foundation, Incorporated | Induction d'une immunité protectrice contre des antigènes |
CN107596361B (zh) * | 2017-09-12 | 2020-08-14 | 浙江海隆生物科技有限公司 | 牛a型产气荚膜梭菌的亚单位疫苗及其制备方法和应用 |
CN107875377B (zh) * | 2017-11-06 | 2020-01-03 | 山东农业大学 | 一种e型产气荚膜梭菌类毒素疫苗的制备方法 |
CN109954135B (zh) * | 2017-12-25 | 2023-01-31 | 金宇保灵生物药品有限公司 | 牛a型产气荚膜梭菌灭活类毒素疫苗及其制备方法 |
CN108578686B (zh) * | 2018-04-23 | 2022-07-01 | 杨凌凯瑞生物科技有限公司 | 一种制备羊梭菌病基因工程亚单位疫苗的方法 |
CN109111509B (zh) * | 2018-09-19 | 2021-08-13 | 天康制药(苏州)有限公司 | 腐败梭菌α毒素突变体、表达其的基因、制备方法和腐败梭菌疫苗 |
CN111500482B (zh) * | 2019-01-31 | 2023-09-05 | 内蒙古金宇保灵生物技术研究院有限公司 | 一种羊a型产气荚膜梭菌菌株及其灭活疫苗和疫苗制备方法 |
CN109943507B (zh) * | 2019-03-26 | 2021-08-17 | 中国兽医药品监察所 | 一种兽用a型产气荚膜梭菌类毒素的制备方法及其应用 |
CN110041437B (zh) * | 2019-04-29 | 2020-12-25 | 中国兽医药品监察所 | 一种无毒性破伤风毒素和诺维梭菌α毒素重组融合蛋白 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2257230B1 (fr) * | 1973-09-14 | 1976-11-19 | Agronomique Inst Nat Rech | |
SU627610A1 (ru) * | 1977-09-30 | 1980-02-05 | Zemlyakova V P | Препарат землаково в.п. против клюстридиозов животных и птиц |
MX9302964A (es) * | 1992-05-20 | 1995-01-31 | Secr Defence | Vacunas de clostridium perfringens. |
DK0692974T4 (da) * | 1993-03-29 | 2007-10-01 | Pfizer | Multikomponent clostridiumvacciner hvor saponin anvendes som adjuvans |
US6048535A (en) * | 1997-06-12 | 2000-04-11 | Regents Of The University Of Minnesota | Multivalent in ovo avian vaccine |
CN101596312A (zh) * | 2002-05-21 | 2009-12-09 | 先灵-普劳有限公司 | 孢子纲物种体外培养的方法及其用途 |
ATE505538T1 (de) | 2003-06-09 | 2011-04-15 | Corixa Corp | Dna-vektoren |
MXPA06001764A (es) | 2003-08-14 | 2006-07-03 | Merial Ltd | Composiciones y vacunas que contienen antigeno(s) de cryptosporidium parvum y de otro patogeno. |
GB2434367B (en) | 2004-10-05 | 2010-05-12 | Diversa Corp | Improved vaccines |
MY149604A (en) * | 2005-04-18 | 2013-09-13 | Schering Plough Ltd | C.perfringens alpha toxoid vaccine |
CA2669765A1 (fr) * | 2006-11-20 | 2008-05-29 | Intervet International B.V. | Utilisation d'une bacterie de clostridium perfringens type c pour la fabrication d'un vaccin |
-
2006
- 2006-04-14 MY MYPI20061722A patent/MY149604A/en unknown
- 2006-04-17 WO PCT/US2006/014669 patent/WO2006113772A1/fr active Application Filing
- 2006-04-17 EP EP06750659.2A patent/EP1874344B1/fr active Active
- 2006-04-17 DK DK06750659.2T patent/DK1874344T3/en active
- 2006-04-17 RU RU2007142337/10A patent/RU2434638C2/ru not_active IP Right Cessation
- 2006-04-17 CA CA2606180A patent/CA2606180C/fr not_active Expired - Fee Related
- 2006-04-17 BR BRPI0610843-1A patent/BRPI0610843B1/pt active IP Right Grant
- 2006-04-17 CN CN2006800218109A patent/CN101198352B/zh not_active Expired - Fee Related
- 2006-04-17 AR AR20060101501A patent/AR054251A1/es not_active Application Discontinuation
- 2006-04-17 US US11/405,198 patent/US8980283B2/en active Active
- 2006-04-17 UA UAA200712804A patent/UA98099C2/uk unknown
- 2006-04-17 TW TW095113660A patent/TWI311057B/zh not_active IP Right Cessation
- 2006-04-17 KR KR1020077026795A patent/KR20080005277A/ko active IP Right Grant
- 2006-04-17 NZ NZ562637A patent/NZ562637A/en not_active IP Right Cessation
- 2006-04-17 PE PE2006000396A patent/PE20061398A1/es not_active Application Discontinuation
- 2006-04-17 JP JP2008507827A patent/JP5243951B2/ja active Active
- 2006-04-17 SG SG2012093878A patent/SG186672A1/en unknown
- 2006-04-17 AU AU2006236365A patent/AU2006236365B2/en not_active Ceased
- 2006-04-17 ES ES06750659.2T patent/ES2583484T3/es active Active
- 2006-04-17 MX MX2007013053A patent/MX2007013053A/es active IP Right Grant
-
2007
- 2007-10-16 CR CR9443A patent/CR9443A/es unknown
- 2007-10-16 IL IL186701A patent/IL186701A0/en not_active IP Right Cessation
- 2007-10-17 TN TNP2007000387A patent/TNSN07387A1/en unknown
- 2007-10-26 MA MA30321A patent/MA29406B1/fr unknown
- 2007-11-05 ZA ZA200709516A patent/ZA200709516B/xx unknown
-
2011
- 2011-12-26 JP JP2011284090A patent/JP2012062330A/ja not_active Withdrawn
-
2015
- 2015-01-29 US US14/608,577 patent/US9662380B2/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA29406B1 (fr) | Vaccin toxoide alpha de c. perfringens | |
CY1123152T1 (el) | Τροποποιημενες πρωτεϊνες rsv f και μεθοδοι χρησης τους | |
MA29714B1 (fr) | Vaccin | |
WO2005116270A3 (fr) | Composition de vaccin contre le virus de la grippe et ses methodes d'utilisation | |
ECSP034447A (es) | Vacunas para proteccion de espectro amplio contra enfermedades causadas por neisseria meningitidis | |
ATE556718T1 (de) | Neisseria meningitidis kombinationimpfstoffe | |
MA30065B1 (fr) | Vaccin | |
WO2007030810A3 (fr) | Moniteur de sang total multiparametrique et procede associe | |
IN2014DN08830A (fr) | ||
MX2010012999A (es) | Vacuna de vesícula de membrana externa nativa multivalente del meningococo, método para su fabricación y uso. | |
HUP0303720A2 (hu) | Egy immunstimuláns oligonukleotidot és egy tokolt tartalmazó adjuvánskészítmény | |
WO2007006712A3 (fr) | Vaccin de sous-unite de mycoplasma | |
WO2006091722A3 (fr) | Vaccination amplifiee par alkyle-glycosides | |
MA29459B1 (fr) | Vaccins | |
PT1154790E (pt) | Reforco da actividade bactericida de antigenios contra a neisseria com oligonucleotidos contendo motivos cg | |
CR11307A (es) | Vacunas | |
ATE458496T1 (de) | Hiv-vakzine und anwendungsverfahren | |
GB2444676A (en) | Adjuvanted vaccine | |
UA107177C2 (uk) | Імуногенна композиція цвс2 та спосіб приготування такої композиції | |
SG163571A1 (en) | Rotavirus vaccine inducing heterotypic cross protection | |
AR065765A1 (es) | Composicion de vacuna para el tratamiento de enfermedades infecciosas respiratorias | |
WO2007086898A3 (fr) | Procedes et compositions relatives a des glycoproteines des spores du charbon | |
WO2010080188A3 (fr) | Vaccin ciblé par épitope contre le charbon | |
EP1667634A4 (fr) | Vaccin contre l'anthrax | |
NZ591738A (en) | Non-typhoidal salmonella vaccines comprising a polypeptide which is an outer membrane protein d of non typoidal salmonella |